Brokerages Set Blueprint Medicines Co. (NASDAQ:BPMC) Target Price at $124.95
Shares of Blueprint Medicines Co. (NASDAQ:BPMC – Get Free Report) have been assigned an average rating of “Moderate Buy” from the twenty-three analysts that are currently covering the company, Marketbeat reports. One research analyst has rated the stock with a sell rating, six have given a hold rating, fifteen have given a buy rating and […]
Shares of Blueprint Medicines Co. (NASDAQ:BPMC – Get Free Report) have been assigned an average rating of “Moderate Buy” from the twenty-three analysts that are currently covering the company, Marketbeat reports. One research analyst has rated the stock with a sell rating, six have given a hold rating, fifteen have given a buy rating and […]
